rs3212985
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_012099.3(POLR1G):c.*327C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 706,458 control chromosomes in the GnomAD database, including 14,092 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2446 hom., cov: 30)
Exomes 𝑓: 0.19 ( 11646 hom. )
Consequence
POLR1G
NM_012099.3 3_prime_UTR
NM_012099.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.184
Publications
7 publications found
Genes affected
POLR1G (HGNC:24219): (RNA polymerase I subunit G) Enables RNA binding activity. Predicted to be involved in transmembrane receptor protein tyrosine kinase signaling pathway. Predicted to act upstream of or within rRNA transcription. Located in cytosol; mitochondrion; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
ERCC1 (HGNC:3433): (ERCC excision repair 1, endonuclease non-catalytic subunit) The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5' incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
ERCC1 Gene-Disease associations (from GenCC):
- cerebrooculofacioskeletal syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Cockayne syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 19-45409828-C-G is Benign according to our data. Variant chr19-45409828-C-G is described in ClinVar as Benign. ClinVar VariationId is 1236680.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POLR1G | NM_012099.3 | c.*327C>G | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000309424.8 | NP_036231.1 | ||
| ERCC1 | NM_001983.4 | c.844-103G>C | intron_variant | Intron 9 of 9 | ENST00000300853.8 | NP_001974.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.164 AC: 24750AN: 151098Hom.: 2449 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
24750
AN:
151098
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.193 AC: 107326AN: 555256Hom.: 11646 Cov.: 0 AF XY: 0.197 AC XY: 59162AN XY: 299624 show subpopulations
GnomAD4 exome
AF:
AC:
107326
AN:
555256
Hom.:
Cov.:
0
AF XY:
AC XY:
59162
AN XY:
299624
show subpopulations
African (AFR)
AF:
AC:
1260
AN:
15406
American (AMR)
AF:
AC:
3833
AN:
33750
Ashkenazi Jewish (ASJ)
AF:
AC:
4333
AN:
19690
East Asian (EAS)
AF:
AC:
340
AN:
31934
South Asian (SAS)
AF:
AC:
13957
AN:
61766
European-Finnish (FIN)
AF:
AC:
8330
AN:
47882
Middle Eastern (MID)
AF:
AC:
607
AN:
2418
European-Non Finnish (NFE)
AF:
AC:
68911
AN:
312338
Other (OTH)
AF:
AC:
5755
AN:
30072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
3940
7880
11821
15761
19701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.164 AC: 24743AN: 151202Hom.: 2446 Cov.: 30 AF XY: 0.162 AC XY: 11956AN XY: 73836 show subpopulations
GnomAD4 genome
AF:
AC:
24743
AN:
151202
Hom.:
Cov.:
30
AF XY:
AC XY:
11956
AN XY:
73836
show subpopulations
African (AFR)
AF:
AC:
3338
AN:
41286
American (AMR)
AF:
AC:
2098
AN:
15158
Ashkenazi Jewish (ASJ)
AF:
AC:
768
AN:
3464
East Asian (EAS)
AF:
AC:
63
AN:
5184
South Asian (SAS)
AF:
AC:
1014
AN:
4778
European-Finnish (FIN)
AF:
AC:
1793
AN:
10294
Middle Eastern (MID)
AF:
AC:
49
AN:
292
European-Non Finnish (NFE)
AF:
AC:
14946
AN:
67740
Other (OTH)
AF:
AC:
362
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
847
1695
2542
3390
4237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
324
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.